Parents
Sign in to add mentor| David Botstein | grad student | 2010 | Princeton | |
| (Genomic analysis of the heat shock response and its relationship to growth rate in Saccharomyces cerevisiae.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Maniakas A, Dadu R, Busaidy NL, et al. (2020) Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. Jama Oncology |
| Hong L, Negrao MV, Dibaj SS, et al. (2020) Programmed Death Ligand 1 Heterogeneity and its Impact on Benefit from Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Cascone T, Sepesi B, Lin H, et al. (2020) A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel and Nintedanib for Resectable Non-Small Cell Lung Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lin SH, Lin Y, Yao L, et al. (2019) Phase II trial of concurrent atezolizumab with chemoradiation in unresectable non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| Tsao AS, Miao J, Wistuba II, et al. (2019) Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900269 |
| Wang JR, Zafereo M, Dadu R, et al. (2019) Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma. Thyroid : Official Journal of the American Thyroid Association |
| Gunn GB, Mendoza TR, Garden AS, et al. (2019) Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer |
| Cabanillas M, Busaidy N, Dadu R, et al. (2019) OR27-6 Combination Vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL1 Inhibitor) in BRAF-V600E Mutated Anaplastic Thyroid Cancer (ATC): Initial Safety and Feasibility Journal of the Endocrine Society. 3 |
| Le X, Pickering CR, Rubin ML, et al. (2019) Induction chemotherapy with and without erlotinib in patients with oral cavity squamous cell carcinomas (OCSCCs) amenable for surgical resection. Journal of Clinical Oncology. 37: 6067-6067 |
| Gao Y, Lu C, Chen H, et al. (2019) P1.01-104 Survivals in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer Treated with First-Line Crizotinib Journal of Thoracic Oncology. 14 |